Market research
DRW3.F Drägerwerk AG & Co. KGaA
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- 11.12
- Analyst target
- 110.25
- Dividend yield
- 2.1%
- Beta
- 0.6
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- DE0005550636
- Market cap
- 2B
- P/E ratio
- 11.12
- Analyst target
- 110.25
- Dividend yield
- 2.1%
- Beta
- 0.6
About
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. In addition, it offers patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. Further, the company offers alcohol and drug testing; diving equipment; fixed gas detectors; hazmat suits; portable gas detection; head and eye protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply, as well as provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Dr. Heinrich Dräger GmbH.
Research context
Drägerwerk AG & Co. KGaA appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the DRW3.F discussion.
5 years, 7 months ago
Drägerwerk AG & Co. KGaA is currently in a long term uptrend where the price is trading 10.8% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
Drägerwerk AG & Co. KGaA's total revenue rose by 26.5% to $1B since the same quarter in the previous year.
Its net income has increased by 158.2% to $115M since the same quarter in the previous year.
Finally, its free cash flow grew by 383.8% to $328M since the same quarter in the previous year.
Based on the above factors, Drägerwerk AG & Co. KGaA gets an overall score of 5/5.